tag:anvisa.feeds.abelhaninja.de,2026:feeds:cmed/substancia/ranibizumabe2026-10-22T15:48:56.207578-03:00anvisa-feedsanvisa-feeds (dados: CMED/ANVISA)tag:anvisa.feeds.abelhaninja.de,2026:feeds:cmed/substancia/ranibizumabe/202610092026-10-22T15:48:56.207578-03:00<p>sem mudanças</p><table class="queue" id="rows"><caption>Lista atual (5 apresentações)</caption><thead><tr><th>Produto</th><th>Apresentação</th><th>Laboratório</th><th>PF 0 %</th><th>PMC 0 %</th><th>PMVG 0 %</th><th class="d">Regime</th></tr></thead><tbody><tr title="GGREM 526518030092303"><td>LUCENTIS</td><td>10 MG/ML SOL INJ CT 1 FA VD INC X 0,23 ML + AGU C/ FILTRO</td><td>NOVARTIS BIOCIENCIAS S.A</td><td class="p">R$ 4.640,69</td><td class="p">R$ 6.396,71</td><td class="p">R$ 3.722,30</td><td class="d">Regulado</td></tr><tr title="GGREM 526515080085503"><td>LUCENTIS</td><td>10 MG/ML SOL INJ CT 1 SER PREENC VD TRANS X 0,165 ML</td><td>NOVARTIS BIOCIENCIAS S.A</td><td class="p">R$ 4.640,69</td><td class="p">R$ 6.396,71</td><td class="p">R$ 3.722,30</td><td class="d">Regulado</td></tr><tr title="GGREM 556925120000407"><td>OPTINÓVIS</td><td>10 MG/ML SOL INJ CT 1 FA VD TRANS X 0,23 ML</td><td>BIONOVIS S.A. - COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA</td><td class="p">R$ 4.640,69</td><td class="p">R$ 6.396,71</td><td class="p">R$ 3.722,30</td><td class="d">Regulado</td></tr><tr title="GGREM 556925120000507"><td>OPTINÓVIS</td><td>10 MG/ML SOL INJ CT 1 FA VD TRANS X 0,23 ML + AGU C/ FILTRO + AGULHA</td><td>BIONOVIS S.A. - COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA</td><td class="p">R$ 4.640,69</td><td class="p">R$ 6.396,71</td><td class="p">R$ 3.722,30</td><td class="d">Regulado</td></tr><tr title="GGREM 574525080002607"><td>RANIVISIO</td><td>10 MG/ML SOL INJ CT FA VD TRANS X 0,23 ML</td><td>BIOMM SA</td><td class="p">R$ 2.718,14</td><td class="p">R$ 3.746,67</td><td class="p">R$ 2.180,22</td><td class="d">Regulado</td></tr></tbody></table>